(Washington, DC, OCTOBER 3, 2013) At last night’s MM&M Awards, MDLinx (www.mdlinx.com), a part of M3 group, walked away the winner in one of healthcare marketing’s most acclaimed and respected competitions.

“We are thrilled to receive such a prestigious award where MDLinx was judged, by top industry leaders, to be the best HCP Media Brand. What makes this win even more gratifying is that this award spans both online and offline entries, and MDLinx still came out on top,” comments Aki Tomaru, CEO of M3 USA. “I can’t say enough about the vision and hard work of MDLinx team, who is relentlessly focused on providing the most valuable information to HCPs, in a thoroughly engaging format, helping them make the most informed decisions for their patients.”

Following two comprehensive rounds of scoring by more than 100 independent industry judges, MDLinx was judged to be the best.

One judge praised MDLinx’s “compelling use of technology and human touch to present relevant information.” Another called it “comprehensive, well-built and informed by its users.”

Speed and breadth of coverage impressed judges. MDLinx’s physician editors sort, rank and summarize each article published in more than 2,000 medical journals and the popular press within 24 hours.

Articles are sorted into 35 specialties and 800 subspecialties. Top-ranked articles are listed in e-newsletters that can be tailored to specialties and subspecialties.

Ads and sponsored content are highly targeted. Users on an ad client’s target list can engage with that client’s content, see their sales rep’s photo and request further engagement.

“A well-executed product that successfully meets the needs of doctors and sponsors,” said a third judge.

And it’s not just the industry judges who know the increasing value of MDLinx to HCPs. US physician membership increased 22% over the last year, while global physician subscribers top 898,000. More than 13 million monthly e-newsletters are sent to all US HCP subscribers.

Members of MDLinx and its sibling SmartestDoc include more than 80% of oncologists, endocrinologists and rheumatologists, and about one in three AMA physicians.

Per comScore, it is the number-one specialty site, the fastest growing site, and number-two primary care site.

The black tie MM&M Award dinner and ceremony was held at Cipriani 42nd Street in New York on October 2, 2013.

About M3 GroupThe M3 Group operates in the US, Asia, and Europe with over 1.2 million physician members globally via its physician websites such as www.m3.com, www.mdlinx.com, www.doctors.net.uk, and www.medigate.net. MDLinx is an award-winning, practical medical information tool used by busy physicians and healthcare professionals to stay up to date with the latest research in the medical field. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.

Physician Recruitment

About Us

Quick Links

A subsidiary of M3 Inc., which is publicly traded on the Tokyo Stock Exchange*, M3 USA provides the life science industry with highly targeted interactive marketing, education, content, and research solutions. Through these means, M3 helps healthcare professionals provide the best care to their patients by enabling them to stay current on the ever-evolving practice of medicine.*For stock information, visit our Bloomberg Business Page.